| answer text |
<p>As with all vaccines and medicines, the safety of the Measles, Mumps and Rubella
(MMR) vaccine remains under continual review by the Medicines and Healthcare products
Regulatory Agency (MHRA). The MHRA uses all available sources of evidence in pharmacovigilance,
including regular review of suspected adverse reactions submitted through the Yellow
Card Scheme, data from clinical and epidemiological studies, the medical literature
and information from pharmaceutical companies and other worldwide regulatory authorities.
The MHRA’s processes and data analysis systems are regularly evaluated to ensure optimal
performance in monitoring the safety of vaccines and medicines.</p><p>The balance
of benefits and risks of MMR vaccine remains overwhelmingly favourable.</p>
|
 |
